The diabetes (db) gene is a recessive obesity mutation in the mouse capable of producing diabetes only through interaction with heretofore undefined modifiers in the genetic background of certain inbred strains. Here we identify the genetic map locations of androgen and estrogen sulfotransferase genes important in maintaining the balance of active sex steroids in the liver. The Std locus encoding dehydroepiandrosterone sulfotransferase was mapped to proximal Chromosome 7, and the Ste locus encoding estrogen sulfotransferase was mapped to Chromosome 5. The db mutation in the diabetes-susceptible C57BL/KsJ strain aberrantly regulated mRNA transcript levels from these two loci. Hepatic Ste mRNA transcripts were increased from undetectable levels in normal males and females to high levels in db/db mice of both sexes. An anomalous suppression of Std transcription was observed in db/db females, but not in normal females. These reciprocal changes in mRNA concentrations in mutant females were reflected by an induction of a high affinity estrogen sulfotransferase activity and a concomitant loss ofdehydroepiandrosterone sulfotransferase activity. These db gene-elicited effects were specific for the sex steroid sulfotransferases since other potential sex steroid metabolizing enzymes (phenol sulfotransferase, sex steroid sulfohydrolase, and UDP-glucuronyltransferase) were unaffected. These aberrant changes would virilize hepatic metabolism in females by increasing the ratio ofactive androgens to estrogens. In human females, non-insulin-dependent diabetes mellitus often develops when visceral obesity and hyperinsulinemia are associated with hyperandrogenization. This study demonstrates that background modifier genes interacting deleteriously with an obesity mutation are not necessarily defective alleles. Rather, some are functional genes whose regulation has been altered by pleiotropic effects of the obesity gene. (J. Clin. Invest.
Introduction
Abdominal (or visceral) obesity in humans is a genetically controlled phenotype constituting a major risk factor for develop-Receivedfor publication 2 August 1993 and in revisedform 21 December 1993. ment of non-insulin-dependent diabetes mellitus (NIDDM) I ( 1) . Although -80% of NIDDM patients are obese, most obese humans do not develop NIDDM. Since NIDDM is genetically heterogeneous, it is presumed that an obese individual must inherit additional mutations producing dysregulation of normal glucose homeostasis to be susceptible to obesity-induced NIDDM. The term "diabesity" has been coined to describe animal models in which obesity is clearly intertwined with the initiation of diabetes (2) . Mice homozygous for the autosomal recessive obesity mutation, diabetes (db, Chromosome 4), provide model systems for dissecting the polygenic interactions required for initiation ofa diabesity syndrome (3) . On certain inbred strain backgrounds (C57BL/KsJ, C3H.SW/ J), the db mutation is diabetogenic in mice of both sexes. On other inbred strain backgrounds (C57BL/6J, 129/Lt), db/db mice of both sexes, although extremely obese, are diabesity resistant. On the C3HeB/FeJ inbred background, diabesity is male sex limited. Orchiectomy blocks diabetes development in C3HeB/FeJ-db/db males, while ovariectomy renders C3HeB/FeJ-db/db females diabetes susceptible (4). Estrogens, which facilitate hepatic glucose uptake and storage in rodents, provide the most effective means ofsuppressing excessive hepatic glucose output in susceptible mice (5) . Given these gender-associated aspects of diabesity control, we hypothesized that genes controlling the balance of active estrogens to androgens in the liver were logical "candidate" genes required for conversion ofan obesity syndrome into a diabesity syndrome.
Diabesity elicited by the db mutation on the C57BL/KsJ (BKs) inbred background has been associated with aberrant hyperandrogenic shifts in hepatic sex steroid metabolism (4, 6) . Sex steroid sulfotransferases (ST) are cytosolic enzymes catalyzing the transfer ofa hydrophilic sulfate moiety onto androgens and estrogens ( Fig. 1 ) . Sulfoconjugated androgens and estrogens do not bind to their receptors. Sulfurylation therefore represents a mechanism for intracellular inactivation of sex steroids and their precursors and provides an important mechanism for maintenance ofgender-dimorphic metabolism in the liver (7, 8) . The androgen prehormone dehydroepiandrosterone (DHEA) is the preferred substrate for androgen ST (DST) . In lean male mice, DST activity is suppressed at puberty, allowing unconjugated DHEA to be converted to potent androgens (4 (-7.4 kb) allowed easy differentiation of the B6 versus SPRET allele in the BC1 DNA panel. Filters were hybridized as described above and washed twice in 0.1X SSC plus 0.1% SDS at 50'C and once at 550C for 30 min. The typing results were entered into The Jackson Laboratory Gene Mapping Resource database for identification of linkage association with previously mapped polymorphic loci in this DNA panel. This database contains a number of loci identified on the basis of motif sequence-tagged PCR products distinguishing the B6 from the SPRET genome ( 12) .
Northern blot analysis. Total RNA was extracted from frozen livers using the single-step isolation method described by Chomczynski and Sacchi ( 13) . Total RNA (10 IMg) was electrophoretically separated in a 1.25% agarose gel containing 10 mM sodium phosphate (pH 6.5), 3% formaldehyde and transferred onto Zetabind (Cuno, Inc., Meridan, CT) by capillary transfer. The RNA was fixed onto the membrane by exposure to ultraviolet light (1,200 MAJ X 100) using the Stratalinker (Stratagene, La Jolla, CA). The blot was hybridized simultaneously with 32P-labeled fl-actin and the rat hydroxysteroid ST cDNA 2-4 probe. The random hexamer radiolabeling, prehybridization, and hybridization procedures were as described previously ( 13 ) . After a 24-h exposure, this blot was erased with boiling 0.2x SSC plus 0.1% SDS 2x 15 min and prehybridized before rehybridization with a radiolabeled rat PST (14) , also provided by Dr. C. Falany. Finally, the rat EST cDNA (10) was used to generate a 32P-labeled cRNA probe by essentially using protocols and reagents supplied with Riboprobee II core system (Promega Corp., Madison, WI). The presence of specific EST mRNA was determined by hybridization ofthe cRNA probe onto this filter. The hybridization was at 60°C for 24 h with 3 X 30-min washes in 0.1x SSC, 0.1% SDS at 70°C. The prehybridization and hybridization conditions were described by Watson et al. ( 15) .
ST assays. Androgen ST (DST) and EST in cytosols were assayed as described previously (4) . A Blank tubes contained the components except for PAPS, and the incubations were performed at 37°C for 10-30 min. The assays were terminated by transferring the 0.5-ml sample to 2.0 ml of 3 M sodium acetate buffer, pH 4.0. Each sample was vortexed for 30 s with 5 ml anhydrous ether. After 2 X 5-ml extraction cycles, 0.5-ml volume of aqueous product was counted for radioactivity using scintillation fluid (Aquasol II; New England Nuclear, Boston, MA).
EST was purified from liver tissue from 16 8-12-wk-old C57BL/ KsJ females. Livers were homogenized in four volumes 0.1 M TrisHCl, pH 7.5, plus 0.25 M sucrose in a Polytron (Brinkman Instruments, Inc., Westbury, NY). The cytosolic portion was clarified by ultracentrifugation for 40 min at 200,000 g. The 35-55% (NH4)2 S04 insoluble-fraction was resuspended in 40 ml of 0.01 M Tris-HCl, pH 7.5, and dialyzed in the same buffer. The clarified dialysis retentate was added onto an equilibrated 70-ml DE52 DEAE cellulose column (2.8 cm X 20 cm) (Bio-Rad Laboratories, Melville, NY). Enzymatically active EST was eluted with two bed volumes of 0.05 M Tris-HCl, pH 7.5. The active fractions were pooled and loaded onto a 5-8-ml adenosine 3',5'-diphosphate agarose affinity column ( 1.8 cm X 10 cm) (BioRad Laboratories) preequilibrated in 0.05 M Tris-HCl, pH 7.5 (elution buffer). This adenosine 3',5'-diphosphate column was washed with three bed volumes elution buffer containing 0.13 M KCl and then with 10 ml of buffer containing 20 MM AMP, and finally reequilibrated in elution buffer. EST activity was eluted by running a linear 40-ml gradient of 0-2.0 MM PAPS in elution buffer.
Sex steroid sulfohydrolase (STS) and UDP-glucuronyltransferase (UDPGT) assays. Replicate pools of six to nine livers from C57BL/ KsJ-db/db or control mice were homogenized separately in 1.15% KCI. The homogenates were centrifuged at 20,000 g for 20 min at 4°C and then were ultracentrifuged 200,000 g for 40 min at 4°C. Microsomes were resuspended in 8.0 ml 1.15% KCI, the protein concentration was determined, and 20-mg aliquots were pelleted by ultracentrifugation and stored at -70°C for up to 3 mo without loss ofactivity. STS was assayed using the procedure described in detail previously (16) with the following modifications. 20 mg of 100,000 g washed microsomal pellets was resuspended in 2.0 ml of0.05 M imidazole buffer, pH 7.2. These suspensions were diluted 1:1 with 0.05 M imidazole, pH 7.2, containing 2% Miranol detergent and solubilized by mixing for 30 min at room temperature. The solubilized portion was clarified by ultracentrifugation as described above. Replicate 50-ul samples were assayed under saturating conditions for 40 min at 37°C.
For glucuronyltransferase assay, mutant or control microsomal pellets (20 mg) were resuspended in 0.6 ml Tris-HCl, pH 8.0, containing 0.01 M MgCl2 (buffer B) and then diluted 1:1 with buffer B, 20 mg/ml Lubrol PA detergent. The microsomes were solubilized by rotating this mixture for 30 min at room temperature, and the solubilized portion was clarified by ultracentrifugation as described above. Replicate 100-,ul samples were assayed for the isoforms of UDPGT under saturating conditions as described in detail by Falany and Tephly (17 in BKs-db/db females was reduced drastically. This decline in mRNA concentration correlates with the previously reported suppression ofDST enzymatic activity (4, 6) . This suppression ofhepatic androgen sulfurylation capacity in mutant females is further exacerbated by the effect of db gene expression on hepatic Ste transcript levels. No constitutive EST mRNA transcripts are detected in liver of lean controls of either sex (Fig.  3 ). This represents a major genera difference between nonobese mice and rats, since in the latter androgen induction ofan EST activity in male liver in addition to androgen suppression of DST is required to maintain a male-imprinted metabolic Sex steroid St gene mapping. Hybridization of rat EST and DST cDNA probes to a panel of 94 BglII-and PvuII-digested DNAs made from (B6 X SPRET) X SPRET backcross.mice localized the Ste gene (ST, estrogen-preferring) to the midpart of mouse Chromosome 5 and the Stdgene (ST, DHEA-preferring) to the proximal region ofChromosome 7. The map positions are schematically shown in Fig. 2 . The position ofthe Stp gene (ST, phenol-preferring) reported previously and located more distally on Chromosome 7 is also shown. Data in Table I show the recombination frequencies for the nearest linkage markers for Ste and Std. No recombinants were found between Ste and DSBirl, the latter marker positioned 45 centimorgan (cM) from the centromere on Chromosome 5. Similarly, no recombinants were found between Std and Pmv-4, the latter marker positioned 2 cM from the centromere on Chromosome 7. These mapping data formally exclude the possibility that the db mutation (on Chromosome 4) represents a variant Ste or Std gene.
The db gene and aberrant changes in St gene transcript concentrations. Northern blot analyses (Fig. 3) demonstrate the aberrant changes in hepatic St gene transcript concentrations elicited by the db mutation. Lean BKs-m+/+ db (control) females, but not males, continue to transcribe DST mRNA after puberty. In contrast, Std transcript concentration (Fig. 3) . Hence, the diabetogenic intei tween the db mutation and St loci is specific for St lc ling the balance of active androgens to estrogens in
The db gene induces a specific EST hepatic isofi heretofore unknown whether the high activity, los hepatic isoform previously reported in BKs-db/db I sented the specific product of de novo Ste gene inc instead, an allosteric modification ofa preexisting gei ficity ST (such as PST) so that its affinity for estrog was increased. To correlate the action of the db g( gene activation with expression of EST, an effort w; purify a db-specific EST activity. Consistent with the absence ofmRNA transcripts in liver oflean BKs controls, an estrogenspecific ST could not be purified using the protocol described in Methods. As shown in Table II the net level ofactive tissue estrogens would not differ from the low levels found in normal mice. In fact, no difference between STS activity in hepatic microsomes from BKs lean versus db/ db mice was observed (data not shown), demonstrating that the consequence of elevated intracellular EST activity would indeed be estrogen inactivation.
Discussion
The present study demonstrates that obesity gene-mediated diabetogenesis in BKs-db/db mice entails aberrant trans-regulation of ST genes whose products control the ratio of functional androgens and estrogens in the liver. The induction of a high affinity EST in mutant mice of both sexes, coupled with loss of ability to sulfurylate androgens in females, would effectively produce a hyperandrogenized metabolic milieu. Estrogens potentiate glucose homeostasis in rodents in part by increasing the density of hepatocyte surface insulin receptors, while androgens antagonize these estrogenic effects ( 19) . Insulin resistance produced by the db mutation has been associated with a marked decrease in the number of hepatocyte plasma membrane insulin receptors (20). This decrease could potentially reflect the decreased ratio of intracellular estrogens to androgens resulting from the inactivation of free estrogens by the induction of the high affinity EST and the suppression of the androgen-inactivating DST. The ability of two unlinked recessive obesity mutations (db and ob [obese, Chromosome 6] ) to induce severe diabetes in BKs females correlates with the ability ofeach mutation to increase estrogen inactivation while suppressing androgen inactivation (6) . The net effects of these pleiotropic changes in gene expression would be a hyperandrogenized hepatic metabolic state. BKs females homozygous for a third recessive obesity gene, fat (fat, Chromosome 8), are diabesity resistant, despite development of comparable obesity and hyperinsulinemia to that produced by the diabetogenic db and ob mutations (6, 21) . BKs-fat/fat females do not exhibit the virilizing shifts in DST and EST activities characteristic of BKs-db/db and -ob/ob females (6) . Thus, the diabetogenic potential of obesity mutations in BKs females correlates well with the ability to produce the hyperandrogenic shifts described above. Further confirmation ofthe diabetogenic significance ofthese hyperandrogenic shifts is provided by analysis of the diabesity resistance of C3HeB/FeJ-db/db females versus susceptibility of BKs-db/db females. Unlike the BKs inbred strain background, genetic modifiers in the C3HeB/FeJ background prevent induction of the high affinity EST hepatic isoform in mice of either sex (4). The sexually dimorphic diabesity observed in C3HeB/FeJ-db/db males requires testicular androgen secretion since adolescent castration prevented diabesity in these males (4) . In contrast, in BKs-db/db males, increases in the level of mRNA transcripts from the Ste locus encoding the high affinity EST isoform apparently provide sufficient disturbance of the androgen/estrogen balance so that diabesity can develop independently of testicular-derived androgens. Thus, the ability of the db mutation to modify the concentration of Ste transcripts encoding the EST isoform associates strongly with differential inbred strain background susceptibility to diabesity and provides important insight as to the nature of the background genomic modifiers required for diabetogenesis.
Hyperinsulinemia is one of the earliest pathophysiologic markers of the disturbed metabolism produced by most murine obesity-producing mutations. BKs-db/db mice develop hyperinsulinemia by day 10 postpartum, before development of insulin resistance, obesity, and hyperglycemia demonstrable during the peripubertal period shortly after weaning (22) . At day 10 postpartum, DST was active in hepatic cytosols of normal and mutant mice of both sexes. Induction of the mutant genotype-restricted high affinity EST activity was not detectable until day 17 postpartum (4). Although hyperinsulinemia progressively becomes more severe with increasing age, the absence of EST induction in severely hyperinsulinemic BKs-fat/ fat mutants indicates that some factor other than hyperinsulinemia is required to activate Ste gene transcription. This factor is very likely to be corticosterone, the major adrenal glucocorticoid in mice. Interestingly, hypercorticosteronemia, an endocrinopathy associated with diabesity in BKs-db/db and -ob/ob mice, has not been observed in an incipient congenic stock of diabesity-resistant BKs-fat/fat mice (23) . Implantation of dexamethasone into diabesity-resistant VY-A V females induced a transient hyperglycemia accompanied by induction of a high affinity EST (24) . This rapid induction ofenzyme activity was accompanied by the appearance of mRNA transcripts not detectable in dexamethasone-untreated mice of any genotype (24) . Since in the present studies nuclear runoff analysis was not performed, we cannot confirm that the failure to detect Ste mRNA in total hepatic RNA from wild-type BKs mice was because of an inactive gene versus an unstable mRNA. However, the magnitude of the dexamethasone-elicited increase in Ste transcript concentration in Avyla female mice is typical of other dexamethasone-inducible transcriptional activations. Indeed, recent unpublished experiments in which 0.5 mg dexamethasone pellets were implanted subcutaneously into diabesity-resistant BKs-fat/fat females elicited an identical response as observed in diabesity-resistant Avy/a females: severe hyperglycemia within 72 h accompanied by induction of high levels of hepatic EST. Thus, it is reasonable to propose that the interaction between a diabetogenic obesity gene and the Ste locus entails transcriptional activation in response to hypercorticosteronemia. It must be emphasized that the presence of the obesity mutation on a susceptible inbred strain background, in addition to hypercorticism, was required to achieve inappropriately high levels ofhepatic glucose output and ensuing hyperglycemia. This point is illustrated forcefully by the fact that, while dexamethasone elicited induction of EST mRNA and enzyme activity into both obese VY-Avy/a and BKs-fat/fat females and their lean littermate controls, hyperglycemia developed only in females expressing the obesity mutations.
The present results are of particular interest in that certain important modifier genes underlying susceptibility to diabesity appear not to represent activity variants abdominal (visceral) forms of obesity that so strongly predispose humans to severe glucose intolerance and NIDDM (24a). Postmenopausal declines in ovarian estrogen production in human females, coupled with increased gonadotrophin release from the pituitary, may elicit excessive ovarian androgen production (polycystic ovary syndrome). The polycystic ovary syndrome is often accompanied by obesity, hyperinsulinemia, peripheral insulin insensitivity, reduced hepatic insulin extraction, and sometimes NIDDM (1, 24a) .
DST activity is present in the liver of human females, and the human gene has been cloned. Based upon the known conservation of syntenic regions between the region of mouse Chromosome 7 containing the Std locus and human Chromosome 19q, we predict that the human locus is found on this chromosome. Although EST is expressed in human fetal and placental tissues, a high affinity EST has not been reported in adult human liver. Based upon syntenic considerations, a human homologue of Ste (mouse Chromosome 5) should be located on human Chromosome 4p. Indeed, the mouse chromosomal location of Stp on distal Chromosome 7 accurately predicted the location of the human homologue on Chromosome 16p. The fact that no EST activity has been found in liver of normal human females does not exclude the possibility that a human Ste locus exists that is not expressed constitutively in adult life. We have been unable to detect Ste transcripts in normal BKs mice of either sex. In normal Sprague-Dawley rats, the gene is transcribed only in postpubertal males, although gene transcription could be induced by dihydrotestosterone treatment of ovariectomized females. The possibility that induction ofa constitutively silent EST-encoding gene occurs in livers of hyperandrogenized females is inherently difficult to test because of the requirement for liver biopsy. Hyperandrogenization in humans is inferred when increased serum testosterone levels are found in conjunction with decreased serum concentrations of DHEA sulfate (DHEA-S) and/or sex hormone-binding globulin (25, 26) . Although high concentrations of sex steroids and their transport molecules in plasma may reflect the quantity of hormone available for specific biologic effects in target tissues, they are not direct indicators of levels of receptor-active steroids within cells. Indeed, steroidogenic enzymes capable of forming active sex steroids from receptor-inactive precursors ("intracrines" such as DHEA or A4-androstenedione) are contained in a variety of extragonadal tissues, such that serum levels of hormones serve primarily as an index of gonadal or adrenal activity. In contrast to the human adrenal, the mouse adrenal does not secrete either DHEA or DHEA-S (27). Rather, the mouse (and the rat) appears to regulate hepatic androgen/estrogen balance primarily via inactivation by specific intracellular enzymes (7). Thus, reduced intracellular DHEA-S in livers of db/db mice is not achieved by decreased output from the adrenal but instead via transcriptional suppression of the Std locus. This, in turn, appears to be a consequence ofintracellular estrogen inactivation resulting from Ste gene expression, since active estrogens are required for continued expression of DST activity in postpubertal females (4) . In summary, the present analysis identifies a new genetic mechanism underlying hyperandrogenicity development in a mouse model of NIDDM.
